Neuland Laboratories Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
₹12,819.35
1858.75 (16.96%)
32.0% undervalued intrinsic discount
₹18,865.25
Fair Value
Price ₹12,819.35
AnalystConsensusTarget ₹18,865.25
Fair Value₹18,865.25
Share Pricen/a
524558 Community Narratives
AN

Fair Value ₹18.87k 32.0% undervalued intrinsic discount
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
Key Takeaways Expansion of manufacturing capacity and complex API focus will enhance revenue momentum, margins, and client acquisition as industry shifts supply chains away from traditional sources. Investments in advanced manufacturing, site expansion, and automation are set to improve cost efficiencies, working capital, and global competitiveness.Read more
54
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN

₹18.87k
32.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
25.02% p.a.
Profit Margin
24.51%
Future PE
42.71x
Price in 2029
₹25.1k
Trending Discussion
Recently Updated Narratives
AN

524558: Peptide Partnership Progress And Upcoming Results Date Will Support Future Upside Potential
Fair Value: ₹18.87k 32.0% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Neuland Laboratories Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- 139.62
- 49.33%
- 11.37%
- 16.3%
About 524558
- Founded
- 1984
- Employees
- 1794
- CEO
- Website
View website
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.